Microorganism for producing l-tryptophan and method for producing l-tryptophan using same
Patent Information
- Application Number
- MYPI2025005256
- Authority / Receiving Office
- MY · MY
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2023-04-19
- Filing Date
- 2024-03-26
- Publication Date
- 2024-10-19
AI Technical Summary
Current methods for producing L-tryptophan using Corynebacterium microorganisms face challenges such as low gluconeogenesis activity in nutrient-rich environments and reduced production due to by-products like acetic acid, which decrease phosphoenol pyruvate levels, necessitating improved strategies to enhance L-tryptophan production capacity.
Introduction of pyruvate and phosphate dekinase proteins derived from Komagatebacter xilinus into Corynebacterium microorganisms to increase L-tryptophan production, specifically through the ppdK gene, which enhances the conversion of ATP and pyruvate to phosphoenolpyruvate, a key precursor in tryptophan biosynthesis.
This approach significantly increases the L-tryptophan production capacity of Corynebacterium microorganisms, overcoming the limitations of low gluconeogenesis and by-product interference, resulting in higher yields of L-tryptophan.
Abstract
Description
L-tryptophan producing microorganism and method for producing L-tryptophan using the same
[0001] The present application relates to a Corynebacterium genus microorganism having L-tryptophan production ability, into which a pyruvate, phosphate dikinase protein derived from Komagataebacter xylinus or a polynucleotide encoding the same has been introduced; a method for producing L-tryptophan, comprising a step of culturing the microorganism in a medium; a composition for producing L-tryptophan, comprising the microorganism, a culture of the microorganism, a fermentation product of the microorganism, or a combination of two or more thereof; and a use of the microorganism for producing L-tryptophan.
[0002]
[0003] The process of producing target substances (e.g., amino acids) from microorganisms has been extensively studied as an environmentally friendly and safe production method. Among these, continuous research has been conducted to produce large quantities of target substances from microorganisms of the genus Corynebacterium. Microorganisms of the genus Corynebacterium (Corynebacterium sp.), particularly Corynebacterium glutamicum, are Gram-positive microorganisms widely used for the production of L-amino acids and other useful substances. To produce the aforementioned L-amino acids and other useful substances, various studies are being conducted to develop high-efficiency production microorganisms and fermentation process technologies.
[0004] L-tryptophan, an essential amino acid, has been widely used as a feed additive, a pharmaceutical ingredient for fluids, and a health food ingredient. L-tryptophan can be produced through chemical synthesis, enzymatic reactions, and fermentation, but direct fermentation using microorganisms is currently the primary method used.
[0005] Microorganisms have an aromatic biosynthetic pathway in which phosphoenol pyruvate (PEP), an intermediate in glycolysis, and E4P (erythrose-4-phosphate), a product of the pentose phosphate pathway, are polymerized by DAHP synthase (3-Deoxy-D-arabinoheptulosonate 7-phosphate synthase, EC 2.5.1.54) during L-tryptophan biosynthesis. Previous studies have demonstrated that among the 20 amino acids, tryptophan requires the highest level of energy for biosynthesis, as demonstrated by actual quantitative analysis in cells (Proc. Natl. Acad. Sci. USA, (2002) V99, pp3695-3700).
[0006] Accordingly, a method to increase biosynthesis by enhancing the expression of the tktA gene (NCBI gene ID: 12931960) encoding transketolase (EC 2.2.1.1) to stably supply the precursor E4P has been studied (Current Opinion in Biotechnology, (2009) V20, pp651-658), and research has been conducted to reduce the use of ATP, a high-energy substance, to maintain the intracellular energy level (FEMS Microbiol Lett, (2009) V297, pp217-224).
[0007] However, gluconeogenesis is generally known to be very low in activity in a nutrient-rich culture environment (J Bacteriol. 2013 Sep, 195(18), 4283-4296.; Nature Communications volume 8, Article number: 14316, 2017), and furthermore, there is a problem that the production of L-tryptophan decreases due to the production of by-products such as acetic acid during the production process of L-tryptophan, which reduces the amount of phosphoenolpyruvate, a tryptophan precursor.
[0008] Therefore, research is still needed to effectively increase L-tryptophan production.
[0009]
[0010] The present inventors completed the present application by confirming that the L-tryptophan production ability of a Corynebacterium microorganism introduced with pyruvate, phosphate dikinase protein (PPDK) derived from Komagataebacter xylinus or a polynucleotide encoding the same increases.
[0011]
[0012] One aspect of the present application provides a microorganism of the genus Corynebacterium having L-tryptophan production ability, into which a pyruvate phosphate dikinase protein derived from Komagataebacter xylinus or a polynucleotide encoding the same has been introduced.
[0013] In one specific example, the pyruvate phosphate dikinase derived from Komagataebacter xylinus may comprise the amino acid sequence of SEQ ID NO: 1.
[0014] In another specific example, the pyruvate phosphate dikinase derived from Komagataebacter xylinus may be encoded by the ppdK gene.
[0015] As a microorganism according to any one of the preceding specific examples, the microorganism of the genus Corynebacterium may be Corynebacterium glutamicum.
[0016] As a microorganism according to any one of the preceding specific examples, the microorganism of the genus Corynebacterium may have an increased ability to produce L-tryptophan compared to a non-modified microorganism.
[0017] Another aspect of the present application provides a method for producing L-tryptophan, comprising the step of culturing a Corynebacterium genus microorganism having L-tryptophan production ability, into which a pyruvate phosphate dikinase protein derived from Komagataebacter xylinus or a polynucleotide encoding the same has been introduced, in a medium.
[0018] In one specific example, the method may further comprise a step of recovering L-tryptophan from the cultured microorganism, a culture of the microorganism, a fermented product of the microorganism, or the culture medium.
[0019] Another aspect of the present application provides a composition for producing L-tryptophan, comprising a Corynebacterium genus microorganism having L-tryptophan production ability, into which a pyruvate, phosphate dikinase protein derived from Komagataebacter xylinus or a polynucleotide encoding the same has been introduced; a culture of the microorganism, a fermentation product of the microorganism, or a combination of two or more thereof.
[0020] Another aspect of the present application provides a use for producing L-tryptophan, comprising a composition comprising a Corynebacterium genus microorganism having L-tryptophan production ability, wherein a pyruvate, phosphate dikinase protein derived from Komagataebacter xylinus or a polynucleotide encoding the same has been introduced; a culture of the microorganism, a fermentation product of the microorganism, or a combination of two or more thereof.
[0021]
[0022] The Corynebacterium genus microorganism having L-tryptophan production ability, into which the pyruvate, phosphate dikinase protein derived from Komagataebacter xylinus of the present application or a polynucleotide encoding the same has been introduced, can produce L-tryptophan at a high yield and can thus be usefully utilized in the industrial production of L-tryptophan.
[0023]
[0024] This is explained in detail as follows. Meanwhile, each description and embodiment disclosed in this application can also be applied to each other description and embodiment. That is, all combinations of the various elements disclosed in this application fall within the scope of this application. Furthermore, the scope of this application is not limited by the specific descriptions described below. Furthermore, numerous papers and patent documents are referenced and cited throughout this specification. The disclosures of the cited papers and patent documents are incorporated into this specification in their entirety by reference to more clearly explain the level of the technical field to which this application belongs and the contents of this application.
[0025]
[0026] definition
[0027]
[0028] As used in the specification and appended claims of this application, the singular articles "a," "an," and "the" include plural referents unless otherwise stated. Furthermore, unless otherwise stated, singular terms include plurals, and plural terms include the singular. Furthermore, in the specification and appended claims of this application, unless otherwise stated, the use of "or" is intended to include "and / or."
[0029]
[0030] In this application, the term "about" may be used before a specific numerical value. As used herein, the term "about" encompasses not only the exact number described after the term, but also a range that is or is nearly that number. Whether a number is or is nearly the specific number described can be determined based on the context in which it is presented. For example, the term "about" may refer to a range of -10% to +10% of a numerical value. In another example, the term "about" may refer to a range of -5% to +5% of a given numerical value. However, this is not a limitation.
[0031]
[0032] In this application, the terms "first, second, third," "i), ii), iii),," or "(a), (b), (c), (d),," may be used to distinguish each component. When the terms are used in connection with steps of a method, use, or analysis, these terms do not imply that they are performed consecutively or in order, for example, there may be no time interval between these steps, they may be performed simultaneously, or they may be performed sequentially, in reverse order, or randomly, with intervals of seconds, minutes, hours, days, or months.
[0033]
[0034] In this application, the term "consisting of" means that the proportion of a specific feature, step, component, or other component(s) described below the term totals 100%. The features, steps, components, or other components described below the term "consisting of" may be essential or mandatory. For example, other than the features, steps, components, or other components described below "consisting of," any other feature, step, component, or other component, or any non-essential feature, step, component, or other component may be excluded.
[0035] In this application, the term "consisting essentially of" means that the presence of one or more unspecified features, steps, components, or other components of the subject matter claimed in this application is not substantially affected by the presence of the unspecified one or more features, steps, components, or other components.
[0036] In this application, the term "comprising" means the presence of a feature, step, component, or other component described below the term, and does not exclude the presence of one or more additional features, steps, components, or other components. The features, steps, components, or other components described below "comprising" in this application may be essential or mandatory, but in some embodiments, other optional or non-essential features, steps, components, or other components may be further included.
[0037]
[0038] proteins, polypeptides
[0039]
[0040] In this application, the term "protein" or "polypeptide" means a polymer or oligomer of consecutive amino acid residues. In this application, "polypeptide," "protein," and "peptide" may be used interchangeably.
[0041] Additionally, in some cases, the “amino acid sequence exhibiting activity” may refer to the “polypeptide,” “protein,” or “peptide,”
[0042] When the above “polypeptide”, “protein”, “peptide” and “amino acid sequence exhibiting activity” have catalytic activity, they may be referred to as “enzymes”.
[0043] In this application, the term "mature polypeptide or mature protein" refers to a polypeptide or protein in a form that lacks a signal sequence or a propeptide sequence. A mature polypeptide or mature protein may be a functional form of a polypeptide or protein. A mature polypeptide or mature protein refers to a polypeptide in its final form after translation and / or after posttranslational modification. For example, examples of such posttranslational modifications may include, but are not limited to, N-terminal processing, C-terminal truncation, glycosylation, phosphorylation, and leader sequence removal.
[0044]
[0045] In this application, amino acid sequences are described in N-terminal → C-terminal orientation unless otherwise indicated.
[0046] In the present application, with respect to an amino acid sequence, it is obvious that a polypeptide or protein “comprising” an amino acid sequence set forth in a specific sequence number, a polypeptide or protein “consisting of” an amino acid sequence set forth in a specific sequence number, or a polypeptide or protein “having” an amino acid sequence set forth in a specific sequence number may also include a polypeptide or protein in which some amino acid(s) are deleted, modified, substituted, conservatively substituted, or added, as long as they have the same or corresponding activity as the polypeptide or protein consisting of the amino acid sequence of the corresponding sequence number. For example, the polypeptide or protein may also include a polypeptide or protein having a sequence addition or deletion that does not alter the function of the protein, a mutation that may occur naturally, a silent mutation thereof, or a conservative substitution within or before or after the polypeptide or protein sequence (N-terminal or C-terminal), as long as they have the same or corresponding activity.
[0047] For example, a polypeptide or protein conjugated with an N-terminal signal (or leader) sequence that is involved in translocation of a protein (polypeptide) co-translationally or post-translationally, or a polypeptide or protein conjugated with another sequence or linker that enables identification, purification, or synthesis of the polypeptide or protein, may also be included in the scope of the polypeptide or protein having the amino acid sequence set forth in the specific sequence number.
[0048] In this application, the term "conservative substitution" refers to the replacement of an amino acid with another amino acid having similar structural and / or chemical properties. Such amino acid substitutions may generally occur based on similarities in the polarity, charge, solubility, hydrophobicity, hydrophilicity, and / or amphipathic nature of the residues. For example, positively charged (basic) amino acids include arginine, lysine, and histidine; negatively charged (acidic) amino acids include glutamic acid and aspartic acid; and amino acids with nonpolar side chains (nonpolar amino acids) include glycine, alanine, valine, leucine, isoleucine, methionine, phenylalanine, tryptophan, and proline; Amino acids with polar or hydrophilic side chains (polar amino acids) include serine, threonine, cysteine, tyrosine, asparagine, and glutamine. As another example, amino acids with charged side chains include arginine, lysine, histidine, glutamic acid, and aspartic acid, while amino acids with uncharged side chains (also called neutral amino acids) include glycine, alanine, valine, leucine, isoleucine, methionine, phenylalanine, tryptophan, proline, serine, threonine, cysteine, tyrosine, asparagine, and glutamine. As another example, phenylalanine, tryptophan, and tyrosine can be classified as aromatic amino acids. As another example, valine, leucine, and isoleucine can be classified as branched amino acids.As another example, the 20 amino acids can be classified into five groups based on size: glycine, alanine, and serine; cysteine, proline, threonine, aspartic acid, and asparagine; valine, histidine, glutamic acid, and glutamine; isoleucine, leucine, methionine, lysine, and arginine; and phenylalanine, tryptophan, and tyrosine. However, this is not necessarily limited to these groups. Typically, conservative substitutions may have little or no effect on the activity of a polypeptide or protein.
[0049]
[0050] genes, polynucleotides
[0051]
[0052] In this application, the term "gene" refers to a polynucleotide encoding a functional molecule and a polynucleotide comprising regions preceding and following the polynucleotide, or a functional RNA. In some embodiments, a gene may have a sequence (intron) inserted between each coding region (exon).
[0053]
[0054] In this application, the terms "polynucleotide," "nucleic acid," or "nucleic acid molecule" refer to a polymer of nucleotides in which nucleotide units (monomers) are covalently bonded to form a long chain, and mean a strand of DNA (e.g., cDNA or genomic DNA) or RNA (e.g., mRNA) of a certain length or longer. In this application, "polynucleotide," "nucleic acid," and "nucleic acid molecule" may be used interchangeably.
[0055]
[0056] identity, homology
[0057]
[0058] In this application, the terms "identity" or "homology" refer to the degree of similarity between two given amino acid or base sequences, which may be expressed as a percentage. In this application, "homology" and "identity" may often be used interchangeably.
[0059] Sequence homology or identity of conserved polynucleotides or polypeptides is determined by standard alignment algorithms, which may be used in conjunction with default gap penalties established by the program being used.
[0060] Whether any two polynucleotide or polypeptide sequences are homologous, similar or identical can be determined using known computer algorithms such as the "FASTA" program using default parameters, for example as in Pearson et al (1988) [Proc. Natl. Acad. Sci. USA 85]: 2444. Alternatively, the Needleman-Wunsch algorithm (Needleman and Wunsch, 1970, J. Mol. Biol. 48: 443-453) as performed in the Needleman program of the EMBOSS package (EMBOSS: The European Molecular Biology Open Software Suite, Rice et al., 2000, Trends Genet. 16: 276-277) (version 5.0.0 or later) or the GAP computer program such as the Smith-Waterman algorithm (Smith and Waterman, Adv. Appl. Math (1981) 2:482) can be determined by comparing the sequence information (GCG program package (Devereux, J., et al, Nucleic Acids Research 12: 387 (1984)), BLASTP, BLASTN, FASTA (Atschul, [S.] [F.,] [ET AL, J MOLEC BIOL 215]: 403 (1990); Guide to Huge Computers, Martin J. Bishop, [ED.,] Academic Press, San Diego, 1994, and [CARILLO et al.](1988) SIAM J Applied Math 48: 1073). For example, homology, similarity, or identity can be determined using BLAST or ClustalW from the National Center for Biotechnology Information database.
[0061]
[0062] Additionally, whether any two polynucleotide sequences have homology, similarity or identity can be determined by a Southern hybridization experiment under defined appropriate hybridization conditions, which can be determined by methods well known to those skilled in the art (e.g., J. Sambrook et al., Molecular Cloning, A Laboratory Manual; F. M. Ausubel et al., Current Protocols in Molecular Biology, John Wiley & Sons, Inc., New York), but are not limited thereto. In practice, homologous or identical polynucleotide sequences can generally hybridize along at least about 50%, 60%, 70%, 80% or 90% of their entire length under stringent conditions.
[0063] In this application, the term "stringent conditions" refers to conditions that allow specific hybridization between polynucleotides. Such conditions are specifically described in the literature (see Sambrook et al., supra, 9.50-9.51, 11.7-11.8). For example, it may be a condition in which polynucleotides having high homology or identity hybridize with each other, polynucleotides having 60% or more, 70% or more, 75% or more, 80% or more, 85% or more, 90% or more, 95% or more, 96% or more, 97% or more, 98% or more, or 99% or more homology or identity hybridize with each other, and polynucleotides having lower homology or identity do not hybridize with each other, or a condition in which washing is performed once, specifically twice or three times, at a salt concentration and temperature equivalent to 60°C, 1ХSSC, 0.1% SDS, specifically 60°C, 0.1ХSSC, 0.1% SDS, and more specifically 68°C, 0.1ХSSC, 0.1% SDS, which is a washing condition of a typical southern hybridization.
[0064] The above hybridization requires that the two nucleotide sequences be complementary, but the hybridized polynucleotides may contain some mismatches between bases, depending on the stringency of the hybridization. The term "complementary" is used to describe the relationship between nucleotide bases that can hybridize with each other. For example, in DNA, adenosine is complementary to thymine, and cytosine is complementary to guanine. Accordingly, the polynucleotides of the present application may include isolated nucleic acid fragments that are complementary in their entirety, as well as substantially similar base sequences.
[0065] For example, a polynucleotide having homology or identity with the polynucleotide of the present application can be hybridized and detected at a Tm value of 55°C. In addition, the Tm value may be, but is not limited to, 60°C, 63°C, or 65°C, and can be appropriately adjusted by a person skilled in the art depending on the purpose.
[0066] The appropriate stringency for hybridizing the polynucleotides depends on the length and degree of complementarity of the polynucleotides, variables which are well known in the art (e.g., J. Sambrook et al., supra).
[0067]
[0068] Nucleic acid structures, vectors, and transformation
[0069]
[0070] The term "nucleic acid construct" in this application means a single or double-stranded nucleic acid molecule that contains one or more regulatory sequences and is artificially synthesized, engineered to contain a specific sequence in a manner that does not exist in nature, or isolated from nature.
[0071]
[0072] The term "vector" as used herein refers to a DNA construct for delivering a target polynucleotide into a suitable host or host cell. For example, it may comprise, but is not limited to, a base sequence of a polynucleotide encoding a target polypeptide operably linked to a suitable expression control region (or expression control sequence) so as to enable expression of the target polypeptide in a suitable host.
[0073] The above expression control region may include a promoter capable of initiating transcription, an optional operator sequence for regulating such transcription, a sequence encoding a suitable mRNA ribosome binding site, and a sequence regulating the termination of transcription and translation. After being transformed into a suitable host cell (microorganism), the vector can replicate or function independently of the host genome, and can be integrated into the genome itself.
[0074] The vector used in the present application is not particularly limited, and any vector known in the art can be used. Examples of commonly used vectors include plasmids, cosmids, viruses, and bacteriophages in a natural or recombinant state. For example, pWE15, M13, MBL3, MBL4, IXII, ASHII, APII, t10, t11, Charon4A, and Charon21A can be used as phage vectors or cosmid vectors, and pDZ series, pDC series, pBR series, pUC series, pBluescriptII series, pGEM series, pTZ series, pCL series, and pET series can be used as plasmid vectors. For example, pDZ, pDC, pACYC177, pACYC184, pCL, pECCG117, pUC19, pBR322, pMW118, pCC1BAC vectors can be used.
[0075] For example, a target polynucleotide can be inserted into a chromosome via a vector for intracellular chromosomal insertion. The insertion of the polynucleotide into the chromosome can be achieved by any method known in the art, for example, homologous recombination, but is not limited thereto. A selection marker for confirming the chromosomal insertion can be additionally included. The selection marker is used to select cells transformed with the vector, i.e., to confirm the insertion of the target polynucleotide, and markers that confer a selectable phenotype, such as drug resistance, nutrient requirement, cytotoxic agent resistance, or expression of a surface polypeptide, can be used. In an environment treated with a selective agent, only cells expressing the selection marker survive or exhibit other phenotypic traits, so that transformed cells can be selected.
[0076] In this application, the term "transformation" refers to changing the genetic characteristics of a host cell (microorganism) by introducing a vector containing a target polynucleotide into the host cell (microorganism). The transformed polynucleotide may be located by insertion into the chromosome of the host cell (microorganism) or may be located extrachromosomally. In addition, the polynucleotide may include DNA or RNA. The polynucleotide may be introduced in an appropriate form depending on the purpose of introduction. For example, a polynucleotide for expressing a target polypeptide may be introduced into a host cell (microorganism) in the form of an expression cassette, which is a genetic construct containing all elements necessary for autonomous expression. The expression cassette may typically include a promoter, a transcription termination signal, a ribosome binding site, and a translation termination signal, which are operably linked to the polynucleotide. The expression cassette may be in the form of an expression vector capable of autonomous replication. Additionally, the polynucleotide may be introduced into a host cell (microorganism) in its own form and operably linked to a sequence required for expression in the host cell (microorganism), but is not limited thereto.
[0077] As used herein, the term "operably linked" refers to a configuration in which a regulatory sequence is positioned appropriately so that the regulatory sequence controls the expression of a coding sequence. Accordingly, "operably linked" includes a regulatory region of a functional domain with a known or desired activity, such as a promoter, terminator, signal sequence, or enhancer region, attached or linked to a target (gene or polypeptide) so that the expression, secretion, or function of the target can be controlled according to the known or desired activity. For example, it may mean that a promoter sequence that initiates and mediates the transcription of a polynucleotide encoding a polypeptide is functionally linked to the polynucleotide sequence.
[0078] As used herein, the term “expression” includes, but is not limited to, any step involved in the production of a polypeptide, such as transcription, post-transcriptional modification, translation, post-translational modification, and secretion.
[0079] As used herein, the term "expression vector" refers to a linear or circular nucleic acid molecule comprising a target polynucleotide sequence and a regulatory sequence operably linked thereto for expression thereof. For example, it may comprise the base sequence of a polynucleotide encoding a target polypeptide operably linked to a suitable expression regulatory region (or expression regulatory sequence) so as to enable expression of the target polypeptide in a suitable host.
[0080] In this application, the term "regulatory sequence" refers to a polynucleotide sequence necessary for controlling the expression of a target polynucleotide sequence. Each regulatory sequence may be a natural sequence (having the same origin) or a foreign sequence (derived from another gene) relative to the coding sequence, or a mutant sequence thereof, or another artificial sequence. Examples of the regulatory sequence include a leader sequence, a polyadenylation sequence, a propeptide sequence, a promoter, a signal peptide sequence, an operator sequence, a sequence encoding a ribosome binding site, and a sequence that controls transcription and translation termination. The minimum unit of the regulatory sequence may include a promoter, a transcription and translation termination sequence.
[0081]
[0082] In this application, the term "genetic recombination" means a natural or artificial process in which elements that make up genes, such as DNA or RNA, are changed from their original sequence during the disassembly and reassembly process.
[0083] As used herein, the term "recombinant gene" refers to a gene with a novel genetic structure resulting from genetic recombination, such as chemical synthesis or genetic engineering techniques. The terms "recombinant gene," "recombinant DNA," and "recombinant polynucleotide" may be used interchangeably in this application. For example, the recombinant gene may include an artificial combination of nucleic acid fragments, such as regulatory sequences, that are not found together in nature.
[0084] In this application, the term “recombinant protein” means a protein produced as a result of genetic recombination.
[0085]
[0086] microorganism
[0087]
[0088] In this application, the term "microorganism (or strain)" includes both wild-type microorganisms and prokaryotic or eukaryotic microorganisms that have undergone genetic modification, either naturally or artificially. It may be a microorganism that has a specific mechanism weakened or increased due to a cause such as the insertion of an external gene or the increased or inactivated activity of an endogenous gene, and may be a microorganism that includes genetic modification for the production of a desired polypeptide, protein, or product. In this application, the terms "microorganism," "strain," "host," and "host cell" may be used interchangeably.
[0089] As used herein, the term "recombinant microorganism" refers to a microorganism that has been genetically modified to exhibit a different genotype and / or phenotype compared to a naturally occurring microorganism (e.g., when the genetic modification affects the nucleic acid sequence coding of the microorganism), and may include any progeny or potential progeny of the microorganism. The terms "recombinant microorganism," "genetically modified microorganism," "recombinant host cell," "recombinant cell," and "recombinant strain" may be used interchangeably in this application. The recombinant microorganism may, for example, express a gene that is not found in its native (non-recombinant) form; may not express a gene that is expressed in its native form; or may express a native gene in a manner different from that in which it is expressed in its native form.
[0090] For example, the microorganism of the present application may be a microorganism (e.g., a recombinant microorganism) into which a pyruvate or phosphate dikinase protein or a polynucleotide encoding the same has been introduced, but is not limited thereto.
[0091] In the present application, the term "microorganism having L-tryptophan production ability" refers to a microorganism capable of producing L-tryptophan within the organism, and may include both a microorganism that does not inherently have L-tryptophan production ability but is endowed with L-tryptophan production ability, and a microorganism that inherently has L-tryptophan production ability. The L-tryptophan production ability may be endowed or enhanced by species improvement.
[0092] In this application, the term "unmodified microorganism (strain)" does not exclude a microorganism (strain) that contains a mutation that may occur naturally, and may refer to a wild-type microorganism (strain) or a natural microorganism (strain) itself, or a microorganism (strain) before its phenotype is changed by a genetic mutation caused by natural or artificial factors. In this application, the term "unmodified microorganism (strain)" may be used interchangeably with "pre-modified microorganism (strain)", "unmodified microorganism (strain)", "parent microorganism", "parent strain", "wild-type microorganism (strain)", "reference microorganism (strain)", or "reference microorganism (strain)". In this application, an unmodified microorganism may refer to a microorganism (strain) into which the pyruvate, phosphate dikinase protein of the present application or a polynucleotide encoding the same is not introduced, or before it is introduced, but is not limited thereto. Additionally, in the present application, the unmodified microorganism may be a microorganism that does not contain a polypeptide consisting of sequence number 1 or a polynucleotide consisting of sequence number 2, but is not limited thereto.
[0093]
[0094] Increased protein (polypeptide) activity
[0095]
[0096] In this application, the term "increase" of protein (polypeptide) activity means that the activity of the protein (polypeptide) within a host cell (microorganism) is increased compared to its intrinsic activity. The increase may be used interchangeably with terms such as activation, up-regulation, overexpression, and enhancement. The host cell (microorganism) may be a prokaryotic or eukaryotic microorganism.
[0097] The increase in the above protein (polypeptide) activity may include the display of a protein (polypeptide) activity that the host cell (microorganism) did not inherently possess, or the display of an enhanced protein (polypeptide) activity compared to the inherent activity or activity before modification.
[0098] For example, the above “exhibiting a protein (polypeptide) activity that was not inherently present” or “exhibiting an improved protein (polypeptide) activity” may be due to, but is not limited to, “introduction of a protein (polypeptide).”
[0099] In this application, the term "introduction" of a protein (polypeptide) means that a gene that a microorganism did not originally possess is expressed within the microorganism, thereby causing the activity of a specific protein to be exhibited, or that the activity of the polypeptide is strengthened, increased, or improved compared to the intrinsic activity of the protein or the activity before modification. For example, this may be due to the introduction of a gene encoding the protein (polypeptide) into a host cell (microorganism). For example, a polynucleotide encoding a specific protein (polypeptide) may be introduced into the chromosome of a host cell (microorganism), or a vector containing a polynucleotide encoding a specific protein (polypeptide) may be introduced into the host cell (microorganism), thereby causing the activity of the protein (polypeptide) to be exhibited or improved.
[0100] The above "intrinsic activity" refers to the activity of a specific protein (polypeptide) originally possessed by a host cell (microorganism) or an untransformed host cell (microorganism) before transformation, when the trait changes due to genetic mutation caused by natural or artificial factors. This may be used interchangeably with "activity before transformation."
[0101] An increase in the activity of a protein (polypeptide) compared to the intrinsic activity means that the activity and / or concentration (expression amount) of the protein (polypeptide) of the host cell (microorganism) is enhanced compared to the activity and / or concentration (expression amount) of the protein (polypeptide) originally present in the host cell (microorganism) before transformation or in the non-transformed host cell (microorganism).
[0102] For example, the increase may be, but is not limited to, an increase in the activity or concentration of the corresponding protein (polypeptide) from a previous state, or an increase in the activity or concentration thereof, typically by at least about 1%, at least about 10%, at least about 25%, at least about 50%, at least about 75%, at least about 100%, at least about 150%, at least about 200%, at least about 300%, at least about 400%, or at least about 500%, up to at least about 1000% or at least about 2000%, relative to the activity or concentration in the host cell (microorganism) before transformation or in the untransformed host cell (microorganism).
[0103] An increase in the activity of the above protein (polypeptide) can be achieved by introducing an exogenous protein (polypeptide) or by increasing the activity of an endogenous protein (polypeptide). Whether the activity of the above protein (polypeptide) has increased can be confirmed by an increase in the activity level of the protein (polypeptide), the expression level, or the amount of a product resulting from the activity of the protein (polypeptide).
[0104] The increase in the activity of the above protein (polypeptide) can be achieved by various methods well known in the art, and is not limited thereto, as long as the activity of the target protein (polypeptide) can be increased compared to the host cell (microorganism) before transformation. Specifically, it may be achieved by using genetic engineering and / or protein engineering, which are routine methods of molecular biology and are well known to those skilled in the art, but are not limited thereto (e.g., Sitnicka et al. Functional Analysis of Genes. Advances in Cell Biology. 2010, Vol. 2. 1-16, Sambrook et al. Molecular Cloning 2012, etc.).
[0105] Specifically, the increase in activity of the protein (polypeptide) of the present application is
[0106] 1) Increase in the intracellular copy number of a polynucleotide encoding a protein (polypeptide);
[0107] 2) Modification of the gene expression control region on the chromosome that codes for a protein (polypeptide) (e.g., introduction of a mutation in the expression control region, replacement with a sequence having stronger activity, or insertion of a sequence having stronger activity);
[0108] 3) Modification of the base sequence encoding the initiation codon or 5'-UTR region of a gene transcript encoding a protein (polypeptide);
[0109] 4) Modification of the amino acid sequence of the protein (polypeptide) so as to increase the activity of the protein (polypeptide);
[0110] 5) Modification of a polynucleotide sequence encoding a protein (polypeptide) such that the activity of the protein (polypeptide) is increased (e.g., modification of a polynucleotide sequence of a protein (polypeptide) encoding gene such that the protein (polypeptide) is modified such that the activity of the protein (polypeptide) is increased);
[0111] 6) Introduction of a foreign protein (polypeptide) that exhibits the activity of a protein (polypeptide) or a foreign polynucleotide encoding the same;
[0112] 7) Codon optimization of polynucleotides encoding proteins (polypeptides);
[0113] 8) Analyzing the tertiary structure of a protein (polypeptide) and selecting the exposed portion to modify or chemically modify; or
[0114] 9) It may be a combination of two or more selected from 1) to 8), but is not particularly limited thereto.
[0115] for example,
[0116] The increase in the intracellular copy number of the polynucleotide encoding the protein (polypeptide) described above 1) may be caused by introducing a vector containing a polynucleotide encoding the protein (polypeptide) operably linked to an appropriate regulatory sequence into a host cell (microorganism). Alternatively, one copy or two or more copies of the polynucleotide encoding the protein (polypeptide) operably linked to an appropriate regulatory sequence may be introduced into a chromosome within the host cell (microorganism). The introduction into the chromosome may be performed by introducing a vector capable of inserting the polynucleotide into the chromosome within the host cell (microorganism), but is not limited thereto. The vector is as described above. The regulatory sequence may be a natural sequence (same in origin) or a foreign sequence (derived from another gene) to the polynucleotide sequence it encodes, or a mutant sequence thereof, or another artificial sequence, and may induce expression of the polynucleotide within the host cell (microorganism).
[0117] 2) The replacement of the gene expression control region (or expression control sequence) on the chromosome encoding the protein (polypeptide) with a sequence having strong activity may be, for example, introducing a mutation in the sequence by deletion, insertion, substitution, or a combination thereof to further increase the activity of the expression control region, or replacement with a sequence having stronger activity. The expression control region may include, but is not particularly limited to, a promoter, an operator sequence, a sequence encoding a ribosome binding site, and a sequence regulating the termination of transcription and translation. As an example, the original promoter may be replaced with a strong promoter, but is not limited thereto.
[0118] Examples of known strong promoters include, but are not limited to, the cj1 to cj7 promoters (US Patent No. US 7662943 B2), the lac promoter, the trp promoter, the trc promoter, the tac promoter, the lambda phage PR promoter, the PL promoter, the tet promoter, the gapA promoter, the SPL7 promoter, the SPL13 (sm3) promoter (US Patent No. US 10584338 B2), the O2 promoter (US Patent No. US 10273491 B2), the tkt promoter, and the yccA promoter.
[0119] The above 3) modification of the base sequence of the region encoding the initiation codon or 5'-UTR of the gene encoding the protein (polypeptide) may be, for example, a modification that encodes another initiation codon having a higher protein (polypeptide) expression rate than the endogenous initiation codon, or an RBS sequence having a higher protein (polypeptide) expression rate than the endogenous RBS (ribosome binding site) sequence, but is not limited thereto.
[0120] The modification of the amino acid sequence or polynucleotide sequence of the protein (polypeptide) of the above 4) and 5) may be, but is not limited to, introducing a sequence mutation by deletion, insertion, substitution, or a combination thereof in the amino acid sequence of the protein (polypeptide) or the polynucleotide sequence encoding the protein (polypeptide) so as to increase the activity of the protein (polypeptide), or replacing it with an amino acid sequence or polynucleotide sequence modified to increase the activity. The replacement may be performed, for example, by inserting a polynucleotide into a chromosome by homologous recombination, but is not limited thereto.
[0121] The introduction of the foreign polynucleotide exhibiting the activity of the above 6) protein (polypeptide) may be the introduction into the host cell (microorganism) of a foreign polynucleotide encoding a protein (polypeptide) exhibiting the same / similar activity as the protein (polypeptide). The foreign polynucleotide is not limited in its origin or sequence as long as it exhibits the same / similar activity as the protein (polypeptide). The method used for the above introduction can be performed by a person skilled in the art appropriately selecting a known transformation method, and the protein (polypeptide) can be produced by expressing the introduced polynucleotide in the host cell, thereby increasing its activity.
[0122] The above 7) codon optimization of a polynucleotide encoding a protein (polypeptide) may be codon optimization of an endogenous polynucleotide to increase transcription or translation within a host cell (microorganism), or codon optimization of a foreign polynucleotide to achieve optimized transcription or translation within a host cell (microorganism).
[0123] The above 8) analyzing the tertiary structure of a protein (polypeptide) and selecting an exposed portion to modify or chemically modify may be done by, for example, comparing the sequence information of the protein (polypeptide) to be analyzed with a database storing the sequence information of known proteins, determining a template protein candidate based on the degree of sequence similarity, confirming the structure based on this, and selecting an exposed portion to modify or chemically modify, and modifying or modifying it.
[0124] Such an increase in protein (polypeptide) activity may be, but is not limited to, an increase in the activity or concentration of the corresponding protein (polypeptide) relative to the activity or concentration of the protein (polypeptide) expressed in the wild type or pre-transformed host cell (microorganism), or an increase in the amount of a product resulting from the activity of the corresponding protein (polypeptide).
[0125]
[0126] Modification of part or all of the polynucleotide in the microorganism of the present application may be induced by, but is not limited to, (a) a method using homologous recombination using a vector for chromosome insertion into the microorganism, or genome editing using genetic scissors (e.g., CRISPR-Cas9) and / or (b) treatment with light and / or chemicals such as ultraviolet rays and radiation.
[0127]
[0128] culture
[0129]
[0130] In this application, the term "cultivation" refers to the growth of microorganisms under appropriately controlled environmental conditions. The cultivation process can be conducted using appropriate media and culture conditions known in the art. This cultivation process can be easily adjusted and used by those skilled in the art depending on the selected microorganism. Specifically, the cultivation process may be batch, continuous, and / or fed-batch, but is not limited thereto.
[0131] In this application, the term "medium" refers to a material containing nutrients necessary for culturing microorganisms as its main component, and supplies nutrients and growth factors, including water, which is essential for survival and growth. Specifically, the medium and other culture conditions used for culturing the microorganisms of this application may be any medium used for culturing conventional microorganisms without particular limitation. For example, the microorganisms of this application may be cultured under aerobic conditions by controlling temperature, pH, etc. in a conventional medium containing appropriate carbon sources, nitrogen sources, phosphorus sources, inorganic compounds, amino acids, and / or vitamins. For example, culture media for microorganisms of the genus Corynebacterium can be found in the literature ["Manual of Methods for General Bacteriology" by the American Society for Bacteriology (Washington DC, USA, 1981)].
[0132] In the present application, the carbon source may include carbohydrates such as glucose, saccharose, lactose, fructose, sucrose, maltose, etc.; sugar alcohols such as mannitol, sorbitol, etc.; organic acids such as pyruvic acid, lactic acid, citric acid, etc.; amino acids such as glutamic acid, methionine, lysine, etc. In addition, natural organic nutrients such as starch hydrolysate, molasses, blackstrap molasses, rice winter, cassava, sugarcane bagasse, and corn steep liquor may be used, and specifically, carbohydrates such as glucose and sterilized pretreated molasses (i.e., molasses converted to reducing sugar) may be used, and other appropriate amounts of carbon sources may be used in various ways without limitation. These carbon sources may be used alone or in combination of two or more, but are not limited thereto.
[0133] The nitrogen source may include inorganic nitrogen sources such as ammonia, ammonium sulfate, ammonium chloride, ammonium acetate, ammonium phosphate, ammonium carbonate, ammonium nitrate, etc.; organic nitrogen sources such as amino acids such as glutamic acid, methionine, glutamine, etc.; peptone, NZ-amine, meat extract, yeast extract, malt extract, corn steep liquor, casein hydrolysate, fish or its decomposition product, defatted soybean cake or its decomposition product, etc. These nitrogen sources may be used alone or in combination of two or more, but are not limited thereto.
[0134] The above-mentioned components may include potassium phosphate monobasic, potassium phosphate dibasic, or their corresponding sodium-containing salts. Inorganic compounds may include sodium chloride, calcium chloride, iron chloride, magnesium sulfate, iron sulfate, manganese sulfate, calcium carbonate, etc. In addition, amino acids, vitamins, and / or suitable precursors may be included. These components or precursors may be added to the medium in batch or continuous manner, but are not limited thereto.
[0135] In addition, during the cultivation of the microorganism of the present application, compounds such as ammonium hydroxide, potassium hydroxide, ammonia, phosphoric acid, sulfuric acid, etc. may be added to the medium in an appropriate manner to adjust the pH of the medium. In addition, during the cultivation, foaming may be suppressed by using an antifoaming agent such as fatty acid polyglycol ester. In addition, to maintain the aerobic state of the medium, oxygen or an oxygen-containing gas may be injected into the medium, or to maintain the anaerobic and microaerobic state, nitrogen, hydrogen, or carbon dioxide gas may be injected without gas injection, but is not limited thereto.
[0136] In the culture of the present application, the culture temperature can be maintained at 20 to 45°C, specifically 25 to 40°C, and the culture can be performed for about 10 to 160 hours, but is not limited thereto.
[0137] In the present application, the term "culture" means a culture solution, concentrated culture solution, dried product of culture solution, culture filtrate, concentrated culture filtrate, or dried product of culture filtrate obtained by culturing a specific microorganism in a culture medium, wherein the culture solution means that it contains a specific microorganism, and the culture filtrate means that it does not substantially contain a specific microorganism (here, substantially means that a specific microorganism separated by filtration or the like is excluded, but does not mean that the filtrate is completely free of microorganisms). The culture is not limited in its formulation, and may be, for example, a liquid, an emulsion, or a solid.
[0138] In this application, the term "fermentation" refers to a process in which microorganisms use their enzymes to decompose organic matter, but not to a putrefaction reaction. While fermentation and putrefaction occur through similar processes, if the resulting decomposition produces useful substances, it is called fermentation. If the resulting decomposition produces foul-smelling or harmful substances, it is called putrefaction.
[0139] In the present application, the method for obtaining a fermented product from the microorganism is not particularly limited, and the product can be obtained according to a method commonly used in the relevant technical field or a similar field.
[0140] In the present application, the term "fermentation" includes all kinds of substances including a fermentation product produced from the microorganism, such as not only the fermented substance itself, but also a substance containing a fermented microorganism, a culture produced from the fermented microorganism, a fermentation product of the culture, a concentrated fermentation product, a dried product of the fermentation product, a filtrate of the fermentation product, a concentrated filtrate of the fermentation product, or a dried product of the fermentation product filtrate, an extract of the fermentation product, or a dilution of the fermentation product.
[0141]
[0142] Specific description of this application
[0143]
[0144] Hereinafter, specific examples of the present application will be described in more detail as follows.
[0145]
[0146] One aspect of the present application provides a microorganism of the genus Corynebacterium having L-tryptophan production ability, into which a pyruvate phosphate dikinase protein derived from Komagataebacter xylinus or a polynucleotide encoding the same has been introduced.
[0147]
[0148]
[0149] In the present application, the term "pyruvate, phosphate dikinase (PPDK)" refers to an enzyme of a family of transferases that catalyzes the reaction [ATP + pyruvate + phosphate ↔ phosphoenolpyruvate (PEP) + diphosphate]. The pyruvate, phosphate dikinase of the present application may be used interchangeably with PPDK. Specifically, the pyruvate, phosphate dikinase of the present application may be a protein having pyruvate, phosphate dikinase activity encoded by the ppdk gene, but is not particularly limited in type as long as it has an activity corresponding to pyruvate, phosphate dikinase. The pyruvate phosphate dikinase encoded by the above ppdk gene is known in the art, and the amino acid and polynucleotide sequences of the pyruvate phosphate dikinase can be obtained from known databases, including, but not limited to, NCBI's GenBank.
[0150] For example, the pyruvate, phosphate dikinase protein derived from Komagataeibacter xylinus may include the amino acid sequence of SEQ ID NO: 1 or an amino acid sequence having 60% or more homology or identity therewith, but is not limited thereto as long as it has pyruvate, phosphate dikinase protein activity. Specifically, even if it includes a sequence in which some sequences are deleted, modified, substituted or added in the amino acid sequence of SEQ ID NO: 1, as long as it is a protein that exhibits an effect corresponding to the pyruvate, phosphate dikinase protein, it may be included in the pyruvate, phosphate dikinase protein. Additionally, a protein having an amino acid sequence having at least 60%, 70%, 80%, 85%, 90%, 95%, 96%, 97%, 98%, or 99% homology or identity with the amino acid sequence of the above sequence number 1, comprising, consisting of, or essentially consisting of the amino acid sequence, and exhibiting an effect corresponding to the above pyruvate phosphate dikinase protein, may be included in the above pyruvate phosphate dikinase protein.
[0151]
[0152] In addition, the sequence of a polynucleotide encoding a pyruvate, phosphate dikinase protein derived from Komagataebacter xylinus having the amino acid sequence of SEQ ID NO: 1 or an amino acid sequence having 60% or more homology or identity therewith can be obtained, for example, based on codon information known in the art. For example, the pyruvate, phosphate dikinase protein may be encoded by a polynucleotide having or including a sequence of SEQ ID NO: 2 or a base sequence having 60% or more, 70% or more, 75% or more, 80% or more, 85% or more, 90% or more, 95% or more, 96% or more, 97% or more, 98% or more, or 99% or more homology or identity with the sequence of SEQ ID NO: 2, or consisting of or consisting essentially of the base sequence, but is not limited thereto. In addition, the base sequence of the above sequence number 2 can be obtained from a known database, such as, but not limited to, NCBI's GenBank.
[0153] In the present application, the polynucleotide (gene) including the base sequence of SEQ ID NO: 2 may be used interchangeably with a polynucleotide (gene) having the base sequence of SEQ ID NO: 2, a polynucleotide (gene) consisting of the base sequence of SEQ ID NO: 2, or ppdk.
[0154] The polynucleotide of the present application may be modified in various ways in the coding region without changing the amino acid sequence of the pyruvate phosphate dikinase protein of the present application due to codon degeneracy or in consideration of the codons preferred in the organism that is intended to express the pyruvate phosphate dikinase protein of the present application. Therefore, it is obvious that the polynucleotide of the present application may also include a polynucleotide that can be translated into a polypeptide consisting of the amino acid sequence of the pyruvate phosphate dikinase protein of the present application or a polypeptide having homology or identity therewith due to codon degeneracy. For example, the polynucleotide of the present application may be SEQ ID NO: 2 or a degenerated sequence thereof.
[0155] As another example, the polynucleotide of the present application may have or include a base sequence that is at least 60%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, or at least 99% homologous or identical to SEQ ID NO: 2, or may consist of or consist essentially of a base sequence that is at least 60%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, or at least 99% homologous or identical to SEQ ID NO: 2, but is not limited thereto.
[0156] In addition, the polynucleotide of the present application may include, without limitation, a probe that can be prepared from a known gene sequence, for example, a sequence that hybridizes under stringent conditions with a complementary sequence to all or part of the polynucleotide sequence of the present application, so long as it encodes the pyruvate phosphate dikinase protein of the present application.
[0157]
[0158] For the purpose of the present application, the microorganism of the present application may include any microorganism capable of producing the desired L-tryptophan by introducing a pyruvate, phosphate dikinase protein or a polynucleotide encoding the same. For example, the microorganism of the present application is characterized by having increased L-tryptophan productivity by introducing a pyruvate, phosphate dikinase protein or a polynucleotide encoding the same, and may be a genetically modified microorganism or a recombinant microorganism, but is not limited thereto. Specifically, the recombinant strain having increased L-tryptophan productivity may be a microorganism having increased L-tryptophan productivity compared to a natural wild-type microorganism or an unmodified microorganism having intrinsic pyruvate, phosphate dikinase activity or lacking intrinsic pyruvate, phosphate dikinase activity, but is not limited thereto.
[0159] For example, a microorganism having L-tryptophan production ability may be a prokaryotic or eukaryotic microorganism strain capable of producing L-tryptophan within the organism, and may include both a microorganism having an inherent L-tryptophan production ability or a microorganism that is endowed with L-tryptophan production ability due to the activity of the pyruvate phosphate dikinase protein introduced in the present application to a parent strain that does not have L-tryptophan production ability. The L-tryptophan production ability may be endowed or enhanced by species improvement.
[0160] The microorganism of the present application may include any microorganism into which a pyruvate or phosphate dikinase protein or a polynucleotide encoding the same has been introduced by various known methods.
[0161]
[0162] For example, the recombinant microorganism having L-tryptophan production ability of the present application may include any microorganism capable of producing L-tryptophan by being transformed through a vector into which a foreign gene encoding pyruvate, phosphate dikinase of the present application, specifically, a foreign gene encoding pyruvate, phosphate dikinase derived from Komagataebacter xylinus, has been introduced.
[0163]
[0164] For example, the microorganism producing the L-tryptophan may be a microorganism into which a polynucleotide sequence encoding a protein comprising an amino acid sequence of SEQ ID NO: 1, or a protein comprising an amino acid sequence having at least 60%, 70%, 75%, 80%, 85%, 90%, 95%, 96%, 97%, 98%, 99%, 99.5%, 99.7%, or 99.9% homology or identity with the amino acid sequence of SEQ ID NO: 1 has been introduced.
[0165] For example, the microorganism producing the L-tryptophan may be a microorganism into which a polynucleotide capable of encoding a protein including an amino acid sequence having at least 80% homology with the amino acid sequence of the sequence number 1; or a polynucleotide including a base sequence of the sequence number 2, or a base sequence having at least 60%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, or at least 99% homology or identity with the base sequence of the sequence number 2 has been introduced.
[0166]
[0167] For example, the microorganism with increased L-tryptophan production capacity of the present application may be a microorganism with increased L-tryptophan production capacity compared to a non-modified microorganism, but is not limited thereto. For example, the non-modified microorganism, which is the target strain for comparing whether or not the L-tryptophan production capacity has increased, may be the CM05-9157 strain, but is not limited thereto.
[0168] For example, the microorganism with increased L-tryptophan productivity may be increased by about 1% or more, specifically, about 1% or more, about 2.5% or more, about 5% or more, about 6% or more, about 7% or more, about 8% or more, about 9% or more, about 10% or more, about 15% or more, about 16% or more, about 17% or more, or about 18% or more (the upper limit is not particularly limited, and may be, for example, about 200% or less, about 150% or less, about 100% or less, about 50% or less, about 45% or less, about 40% or less, about 35% or less, about 30% or less, about 25% or less, or about 20% or less) compared to the L-tryptophan productivity of the parent microorganism (parent strain) or the non-mutated microorganism before mutation. As long as it has a + value increase compared to the productivity, it is not limited thereto. In another example, the recombinant strain with increased L-tryptophan productivity may have an L-tryptophan productivity increased by about 1.1 times or more, about 1.15 times or more, about 1.16 times or more, about 1.17 times or more, or about 1.18 times or more (the upper limit is not particularly limited, and may be, for example, about 10 times or less, about 5 times or less, about 3 times or less, about 2 times or less, about 1.5 times or less, about 1.4 times or less, about 1.3 times or less, or about 1.2 times or less) compared to the parent microorganism (parent strain) before mutation or the unmodified microorganism, but is not limited thereto.
[0169]
[0170] For example, the microorganism having L-tryptophan production ability of the present application may be either a prokaryotic cell or a eukaryotic cell, but may specifically be a prokaryotic cell. The prokaryotic cell may include, but is not limited to, a microorganism belonging to the genus Escherichia, the genus Erwinia, the genus Serratia, the genus Providencia, the genus Corynebacteria, the genus Pseudomonas, the genus Leptospirasp, the genus Salmonella, the genus Brevibacteria, the genus Hypomononas, the genus Chromobacterium, and the genus Norcardia, or a fungus or yeast. Specifically, the prokaryotic cell may include a microorganism belonging to the genus Escherichia, the genus Corynebacterium, the genus Leptospira, and a yeast. More specifically, it may be a microorganism of the genus Corynebacterium.
[0171] As a microorganism according to any one of the preceding specific examples, the microorganism of the present application may be a microorganism of the genus Corynebacterium.
[0172] As an example of the present application, the microorganism of the present application is Corynebacterium glutamicum, Corynebacterium crudilactis, Corynebacterium deserti, Corynebacterium efficiens, Corynebacterium callunae, Corynebacterium stationis, Corynebacterium singulare, Corynebacterium halotolerans, Corynebacterium striatum, Corynebacterium ammoniagenes, Corynebacterium It may be Corynebacterium pollutisoli, Corynebacterium imitans, Corynebacterium testudinoris, or Corynebacterium flavescens. Specifically, the microorganism of the present application may be a microorganism of the genus Corynebacterium, more specifically, Corynebacterium glutamicum, but is not limited thereto.
[0173] Specifically, the microorganism of the present application may be a microorganism of the genus Corynebacterium, more specifically, Corynebacterium glutamicum, but is not limited thereto.
[0174] Meanwhile, the Corynebacterium genus microorganism having L-tryptophan production ability of the present application may include a natural wild-type microorganism itself, a Corynebacterium genus microorganism having improved L-tryptophan production ability by increasing or decreasing the activity of a gene related to the L-tryptophan production mechanism, or a Corynebacterium genus microorganism having improved L-tryptophan production ability by introducing or increasing the activity of an external gene.
[0175]
[0176] Another aspect of the present application provides a method for producing L-tryptophan, comprising the step of culturing a Corynebacterium genus microorganism having L-tryptophan production ability, into which a pyruvate phosphate dikinase protein derived from Komagataebacter xylinus of the present application or a polynucleotide encoding the same has been introduced, in a medium.
[0177] In the method of the present application, any culture conditions and methods known in the art can be used to cultivate microorganisms. Those skilled in the art can easily adjust and use these culture processes depending on the selected microorganism.
[0178] L-tryptophan produced by the culture of the present invention may be secreted into the medium or remain within the cells.
[0179]
[0180] In one specific example, the method for producing L-tryptophan of the present application may further include a step of preparing a microorganism of the present application, a step of preparing a medium for culturing the strain, or a combination thereof (in any order), for example, prior to the culturing step.
[0181] The L-tryptophan production method of the present application may further include a step of recovering the target substance, specifically L-tryptophan, from the cultured microorganism, the culture of the microorganism, the fermented product of the microorganism, or the culture medium. The recovering step may be additionally included after the culturing step.
[0182] The above recovery may be performed by collecting the target L-tryptophan using a suitable method known in the art according to the culture method of the microorganism of the present application, for example, a batch, continuous or fed-batch culture method. For example, various chromatographies such as centrifugation, filtration, treatment with a crystallized protein precipitant (salting out method), extraction, ultrasonic disruption, ultrafiltration, dialysis, molecular sieve chromatography (gel filtration), adsorption chromatography, ion exchange chromatography, affinity chromatography, HPLC or a combination thereof may be used, and the target substance, specifically L-tryptophan, may be recovered from the medium or microorganism using a suitable method known in the art.
[0183] Additionally, the L-tryptophan production method of the present application may additionally include a purification step. The purification may be performed using any suitable method known in the art. In one example, if the L-tryptophan production method of the present application includes both a recovery step and a purification step, the recovery step and the purification step may be performed sequentially or discontinuously, regardless of the order, or may be performed simultaneously or integrated into a single step, but is not limited thereto.
[0184] In the method of the present application, pyruvate, phosphate dikinase, introduction and L-tryptophan, etc. are as described in the other embodiments above.
[0185]
[0186] Another aspect of the present application provides a composition for producing L-tryptophan, comprising a Corynebacterium genus microorganism having L-tryptophan production ability, into which a pyruvate, phosphate dikinase protein derived from Komagataebacter xylinus of the present application or a polynucleotide encoding the same has been introduced; a culture of the microorganism, a fermentation product of the microorganism, or a combination of two or more thereof.
[0187] The composition of the present application may further comprise any suitable excipient commonly used in compositions for producing L-tryptophan, and such excipients may be, for example, but are not limited to, preservatives, wetting agents, dispersing agents, suspending agents, buffering agents, stabilizers, or isotonic agents.
[0188] In one specific example, each component present in the composition of the present application may be included in a microbiologically effective amount, or an amount that can be suitably present in the composition for production.
[0189] In the composition of the present application, pyruvate, phosphate dikinase, induction and L-tryptophan, etc. are as described in the other embodiments above.
[0190]
[0191] Another aspect of the present application provides a use for producing L-tryptophan by a microorganism of the genus Corynebacterium having L-tryptophan production ability, into which a pyruvate, phosphate dikinase protein derived from Komagataebacter xylinus of the present application or a polynucleotide encoding the same has been introduced.
[0192] In the purposes of the present application, pyruvate, phosphate dikinase, induction and L-tryptophan, etc. are as described in the other embodiments above.
[0193]
[0194] The present application will be described in more detail below through examples. However, the following examples are merely preferred embodiments intended to illustrate the present application and are therefore not intended to limit the scope of the present application. Furthermore, technical details not described herein can be readily understood and implemented by those skilled in the technical field of the present application or similar fields.
[0195]
[0196] Example 1. Exploration and selection of phosphoenolpyruvate synthase (ppsA) or pyruvate, phosphate dikinase (ppdK) genes.
[0197]
[0198] To identify phosphoenolpyruvate synthase or pyruvate, phosphate dikinase with high gluconeogenic activity, we searched for organisms derived from acetic acid bacteria and methanogens that utilize carbon sources consisting of 1 to 3 carbons based on the results of a literature review. Among them, considering the biosafety level applicable to the production strain and the possibility of acquisition, four microorganisms expected to possess phosphoenolpyruvate synthase or pyruvate, phosphate dikinase were selected as shown in Table 1 below.
[0199]
[0200] SequenceStrainProteinRegistrationNo.GenomeRegistrationNo.BiosafetyLevel1Komagataeibacter xylinusWP_007399515.1NZ_CP024644.112Acetobacter pasteurianus subsp.ASC06387.1NZ_CP021922.113Methanosarcina acetivorans str. C2AWP_011023333.1NZ_AE010299.114Escherichia coliWP_000069375.1NZ_CP084899.115Corynebacterium glutamicum ATCC13869WP_011013725.1NZ_CP016335.11
[0201] Example 2. Production of L-tryptophan-producing microorganisms introducing foreign pyruvate and phosphate dikinases.
[0202]
[0203] Example 2-1. Construction of plasmids for gene insertion
[0204]
[0205] A plasmid was constructed to introduce the genes of pyruvate, phosphate dikinase, or phosphoenolpyruvate synthase into the transposon gene site of the chromosome of Corynebacterium glutamicum by homologous recombination.
[0206] Specifically, PCR was performed using the chromosomal DNA of Corynebacterium glutamicum ATCC13869 as a template, primer pairs of SEQ ID NO: 11 and SEQ ID NO: 12, and primer pairs of SEQ ID NO: 13 and SEQ ID NO: 14, to obtain each fragment. PCR was performed using Solg TM Using Pfu-X DNA polymerase, the reaction was performed under the following conditions: denaturation at 95°C for 4 minutes, denaturation at 95°C for 30 seconds, annealing at 60°C for 30 seconds, polymerization at 72°C for 50 seconds (27 cycles), and then polymerization at 72°C for 5 minutes. The primer sequences used are shown in Table 2 below.
[0207]
[0208] Sequence number name Sequence (5'→3') Sequence number 11HR1 FAATTCGAGCTCGGTACCCGATGGAACTACGAGACTGSequence number 12HR1 RTGACAATCACCGCATCCagtactGGATATTCGAGACAGCTTSequence number 13HR2 FGCTGTCTCGAATATCCagtactGGATGCGGTGATTGTCAGSequence number 14HR2 RGGTCGACTCTAGAGGATCCCCTAACCACGACGACTGCAA
[0209] The two fragments amplified through the above PCR and the transformation vector pDCM2 (Korean Patent No. 10-2278000) digested with SmaI restriction enzyme were cloned using the Gibson assembly method (DG Gibson et al., NATURE METHODS, VOL.6 NO.5, MAY 2009, NEBuilder HiFi DNA Assembly Master Mix) to obtain a recombinant plasmid, which was named pDCM2-△Tn.
[0210]
[0211] Example 2-2. Production of a Corynebacterium microorganism introducing pyruvate and phosphate dikinase derived from Komagataeibacter xylinus.
[0212]
[0213] In order to introduce the gene ppdK (NZ_ CP024644.1, SEQ ID NO: 2) encoding pyruvate, phosphate dikinase (SEQ ID NO: 1) derived from Komagataeibacter xylinus (K. xylinus) into Corynebacterium glutamicum, the ppdK gene (SEQ ID NO: 2) of K. xylinus synthesized using the gene synthesis service of Bionics Co., Ltd. was used as a template, and PCR was performed using the primer pairs of SEQ ID NO: 15 and SEQ ID NO: 16 to amplify the ppdK gene.
[0214] Polymerase is Solg TM Pfu-X DNA polymerase was used, and PCR amplification conditions were as follows: denaturation at 95°C for 2 minutes, denaturation at 95°C for 20 seconds, annealing at 60°C for 40 seconds, polymerization at 72°C for 1 minute, repeated 27 times, and then polymerization reaction at 72°C for 5 minutes.
[0215]
[0216] Sequence number name Sequence (5'→3') Sequence number 15ppdK(K.xy)-FcgaaaggaaacactcATGACCAAATGGGTTTACAGC Sequence number 16ppdK(K.xy)-RAATCACCGCATCCagtTCAGGCCGGGCTGGC
[0217] In addition, to secure the Pcj7 promoter, PCR was performed using primers of SEQ ID NO: 17 and SEQ ID NO: 18 using p117-cj7-gfp (US 7662943 B2) as a template. The polymerase was Solg TM Pfu-X DNA polymerase (SolGent co.) was used, and the PCR amplification conditions were as follows: denaturation at 95°C for 2 minutes, denaturation at 95°C for 20 seconds, annealing at 60°C for 40 seconds, polymerization at 72°C for 30 seconds, repeated 27 times, and then polymerization was performed at 72°C for 5 minutes.
[0218]
[0219] Sequence number name Sequence (5'→3') Sequence number 17 Pcj7-FTCTCGAATATCCagtagaaacatcccagcgctact Sequence number 18 Pcj7(K.xy)-RAACCCATTTGGTCATgagtgtttcctttcgttggg
[0220] Next, the amplified K. xylinus ppdK gene, Pcj7 promoter region, and pDCM2-△Tn constructed in Example 2-1, which was cut with ScaI restriction enzyme, were cloned using the Gibson assembly method (DG Gibson et al., NATURE METHODS, VOL.6 NO.5, MAY 2009, NEBuilder HiFi DNA Assembly Master Mix) to obtain a recombinant plasmid, which was named pDCM2-△Tn:: Pcj7-ppdK(K.xy). Cloning was performed by mixing the Gibson assembly reagent and each fragment in the calculated molar number and then storing it at 50℃ for 1 hour.
[0221]
[0222] The above-constructed pDCM2-△Tn:: Pcj7-ppdK(K.xy) vector was transformed into the tryptophan-producing strain CM05-9157 (Korean Patent No. 10-2278000) by electroporation (Appl. Microbiol. Biotechnol. (1999) 52:541-545), and a second crossing-over process was performed to obtain a strain in which one copy of the Pcj7-ppdK(K.xy) gene was inserted between transposon genes on the chromosome. The strain was identified by PCR using primers of SEQ ID NOs: 19 and 20, which can amplify the external regions of the upstream and downstream regions of the inserted gene, respectively, and by sequencing.
[0223]
[0224] Sequence number name Sequence (5'→3') Sequence number 19 Confirm-Pcj7-ppsA / ppdK-FAACAACACCACATCTACATC Sequence number 20 Confirm-Pcj7-ppsA / ppdK-RCAGCCTTTTCCAGCACCA
[0225] The strain obtained by the above method was named CM05-9157 :: Pcj7-ppdK(K.xy).
[0226]
[0227] Example 2-3. Production of a Corynebacterium spp. microorganism introducing pyruvate and phosphate dikinase derived from Acetobacter pasteurianus subsp.
[0228]
[0229] In order to introduce a gene (NZ_CP021922.1, SEQ ID NO: 4) encoding pyruvate, phosphate dikinase (SEQ ID NO: 3) from Acetobacter pasteurianus subsp. into Corynebacterium glutamicum, the ppdK gene was amplified by PCR using the primer pairs of SEQ ID NO: 21 and SEQ ID NO: 22 using the pddK gene (SEQ ID NO: 4) of Acetobacter pasteurianus subsp. synthesized using the gene synthesis service of Bionics Co., Ltd. as a template. The polymerase was Solg TM Pfu-X DNA polymerase was used, and PCR amplification conditions were as follows: denaturation at 95°C for 2 minutes, denaturation at 95°C for 20 seconds, annealing at 60°C for 40 seconds, polymerization at 72°C for 1 minute, repeated 27 times, and then polymerization reaction at 72°C for 5 minutes.
[0230]
[0231] Sequence number name sequence (5'→3') Sequence number 21 ppdK (A.pa) - FcgaaaggaaacactcATGCGCAATCTCCTCGGC Sequence number 22 ppdK (A.pa) - RGCTGACAATCACCGCATCCagtTCAGGCTTTTACGGCCTTG
[0232] In addition, to secure the Pcj7 promoter, PCR was performed using primers of SEQ ID NO: 17 and SEQ ID NO: 23 using p117-cj7-gfp (US 7662943 B2) as a template. The polymerase was Solg TMPfu-X DNA polymerase (SolGent co.) was used, and the PCR amplification conditions were as follows: denaturation at 95°C for 2 minutes, denaturation at 95°C for 20 seconds, annealing at 60°C for 40 seconds, polymerization at 72°C for 30 seconds, repeated 27 times, and then polymerization was performed at 72°C for 5 minutes.
[0233]
[0234] Sequence number name sequence (5'→3') Sequence number 23Pcj7(A.pa)-RGAGGAGATTGCGCATgagtgtttcctttcgttggg
[0235] Next, the amplified ppdK gene of Acetobacter pasteurianus subsp., the Pcj7 promoter region, and the pDCM2-△Tn constructed in Example 2-1, which was digested with ScaI restriction enzyme, were cloned using the Gibson assembly method (DG Gibson et al., NATURE METHODS, VOL.6 NO.5, MAY 2009, NEBuilder HiFi DNA Assembly Master Mix) to obtain a recombinant plasmid, which was named pDCM2-△Tn:: Pcj7-ppdK(A.pa). Cloning was performed by mixing the Gibson assembly reagent and each fragment in the calculated molar number and then storing it at 50℃ for 1 hour.
[0236]
[0237] Next, the constructed pDCM2-△Tn:: Pcj7-ppdK(A.pa) vector was transformed into the tryptophan-producing strain CM05-9157 (Korean Patent No. 10-2278000) by electroporation (Appl. Microbiol. Biotechnol. (1999) 52:541-545), and a second crossing over process was performed to obtain a strain in which one copy of the Pcj7-ppdK(A.pa) gene was inserted between transposon genes on the chromosome. The strain was identified by PCR using primers of SEQ ID NOs: 19 and 20, which can amplify the external regions of the upstream and downstream regions of the inserted gene, respectively, and by sequencing.
[0238]
[0239] The strain obtained by the above method was named CM05-9157 :: Pcj7-ppdK(A.pa).
[0240]
[0241] Example 2-4. Production of a Corynebacterium spp. microorganism introducing pyruvate and phosphate dikinase derived from Methanosarcina acetivorans str. C2A.
[0242]
[0243] To introduce a gene (NZ_AE010299.1, SEQ ID NO: 6) encoding pyruvate phosphate dikinase (SEQ ID NO: 5) derived from Methanosarcina acetivorans str. C2A into Corynebacterium glutamicum, the ppdK gene (SEQ ID NO: 6) of Methanosarcina acetivorans str. C2A synthesized using the gene synthesis service of Bionics Co., Ltd. was used as a template, and PCR was performed using the primer pairs of SEQ ID NO: 24 and SEQ ID NO: 25 to amplify the ppdK gene.
[0244] Polymerase is Solg TMPfu-X DNA polymerase was used, and PCR amplification conditions were as follows: denaturation at 95°C for 2 minutes, denaturation at 95°C for 20 seconds, annealing at 60°C for 40 seconds, polymerization at 72°C for 1 minute, repeated 27 times, and then polymerization reaction at 72°C for 5 minutes.
[0245]
[0246] Sequence number name Sequence (5'→3') Sequence number 24 ppdK (M.ac) - FacgaaaggaaacactcATGCCTGGAGATAAAAACAAATACATC Sequence number 25 ppdK (M.ac) - RAATCACCGCATCCagtTCAGAGCTCCTTTTCAGTTTC
[0247] In addition, to secure the Pcj7 promoter, PCR was performed using primers of SEQ ID NO: 17 and SEQ ID NO: 26 using p117-cj7-gfp (US 7662943 B2) as a template. The polymerase was Solg TM Pfu-X DNA polymerase (SolGent co.) was used, and the PCR amplification conditions were as follows: denaturation at 95°C for 2 minutes, denaturation at 95°C for 20 seconds, annealing at 60°C for 40 seconds, polymerization at 72°C for 30 seconds, repeated 27 times, and then polymerization was performed at 72°C for 5 minutes.
[0248]
[0249] Sequence number name sequence (5'→3') Sequence number 26Pcj7(M.ac)-RTTTATCTCCAGGCATgagtgtttcctttcgttggg
[0250] Next, the ppdK gene of Methanosarcina acetivorans str. C2A amplified from the above, the Pcj7 promoter region, and the pDCM2-△Tn constructed in Example 2-1, which was cut with the ScaI restriction enzyme constructed in Example 2-1, were cloned using the Gibson assembly method (DG Gibson et al., NATURE METHODS, VOL.6 NO.5, MAY 2009, NEBuilder HiFi DNA Assembly Master Mix), thereby obtaining a recombinant plasmid, which was named pDCM2-△Tn:: Pcj7-ppdK(M.ac). Cloning was performed by mixing the Gibson assembly reagent and each fragment in the calculated molar number and then storing it at 50℃ for 1 hour.
[0251]
[0252] Next, the constructed pDCM2-△Tn:: Pcj7-ppdK(M.ac) vector was transformed into the tryptophan-producing strain CM05-9157 (Korean Patent No. 10-2278000) by electroporation (Appl. Microbiol. Biotechnol. (1999) 52:541-545), and a second crossing over process was performed to obtain a strain in which one copy of the Pcj7-ppdK(M.ac) gene was inserted between transposon genes on the chromosome. The strain was identified by PCR using primers of SEQ ID NOs: 19 and 20, which can amplify the external regions of the upstream and downstream regions of the inserted gene, respectively, and by sequencing.
[0253]
[0254] The strain obtained by the above method was named CM05-9157 :: Pcj7-ppdK(M.ac).
[0255]
[0256] Example 2-5. Production of Corynebacterium microorganisms introducing pyruvate and phosphate dikinase from Escherichia coli.
[0257]
[0258] To introduce the gene ppsA (NZ_CP084899.1, SEQ ID NO: 8) encoding phosphoenolpyruvate synthase (SEQ ID NO: 7) from Escherichia coli, which is an ortholog of the pyruvate phosphate dikinase gene (ppdk) into Corynebacterium glutamicum.
[0259] First, the ppsA gene was amplified by PCR using Escherichia coli W3110 chromosomal DNA as a template and the primer pair of SEQ ID NO: 27 and SEQ ID NO: 28. The polymerase was Solg TM Pfu-X DNA polymerase was used, and PCR amplification conditions were as follows: denaturation at 95°C for 2 minutes, denaturation at 95°C for 20 seconds, annealing at 60°C for 40 seconds, polymerization at 72°C for 1 minute, repeated 27 times, and then polymerization reaction at 72°C for 5 minutes.
[0260]
[0261] Sequence number name sequence (5'→3') Sequence number 27 ppsA (E.co) - FaacgaaaggaaacactcATGTCCAACAATGGCTCG Sequence number 28 ppsA (E.co) - RAATCACCGCATCCagtTTATTTCTTCAGTTCAGCCAGG
[0262] In addition, to secure the Pcj7 promoter, PCR was performed using primers of SEQ ID NO: 17 and SEQ ID NO: 29 using p117-cj7-gfp (US 7662943 B2) as a template. The polymerase was Solg TM Pfu-X DNA polymerase (SolGent co.) was used, and the PCR amplification conditions were as follows: denaturation at 95°C for 2 minutes, denaturation at 95°C for 20 seconds, annealing at 60°C for 40 seconds, polymerization at 72°C for 30 seconds, repeated 27 times, and then polymerization was performed at 72°C for 5 minutes.
[0263]
[0264] Sequence number name sequence (5'→3') Sequence number 29Pcj7(E.co)-RGCCATTGTTGGACATgagtgtttcctttcgttggg
[0265] Next, the amplified Escherichia coli ppsA gene, Pcj7 promoter region, and pDCM2-△Tn constructed in Example 2-1, which was cut with ScaI restriction enzyme, were cloned using the Gibson assembly method (DG Gibson et al., NATURE METHODS, VOL.6 NO.5, MAY 2009, NEBuilder HiFi DNA Assembly Master Mix) to obtain a recombinant plasmid, which was named pDCM2-△Tn:: Pcj7-ppsA(E.co). Cloning was performed by mixing the Gibson assembly reagent and each fragment in the calculated molar number and then storing it at 50°C for 1 hour.
[0266]
[0267] Next, the constructed pDCM2-△Tn:: Pcj7-ppsA(E.co) vector was transformed into the tryptophan-producing strain CM05-9157 (Korean Patent No. 10-2278000) by electroporation (Appl. Microbiol. Biotechnol. (1999) 52:541-545), and a second crossing-over process was performed to obtain a strain in which one copy of the Pcj7-ppsA(E.co) gene was inserted between transposon genes on the chromosome. The strain was identified by PCR using primers of SEQ ID NOs: 19 and 20, which can amplify the external regions of the upstream and downstream regions of the inserted gene, respectively, and by sequencing.
[0268]
[0269] The strain obtained by the above method was named CM05-9157 :: Pcj7-ppsA(E.co).
[0270]
[0271] Example 2-6. Production of an introduced Corynebacterium spp. microorganism containing pyruvate and phosphate dikinase derived from Corynebacterium glutamicum ATCC13869.
[0272]
[0273] To introduce the gene ppsA (NZ_CP016335.1, SEQ ID NO: 10) encoding phosphoenolpyruvate synthase (SEQ ID NO: 9) from Corynebacterium glutamicumATCC13869, which is an ortholog of the pyruvate phosphate dikinase gene (ppdk) in Corynebacterium glutamicum, pyruvate
[0274] First, the ppsA gene was amplified by PCR using the chromosomal DNA of Corynebacterium glutamicum ATCC13869 as a template and the primer pair of SEQ ID NO: 30 and SEQ ID NO: 31. The polymerase was Solg TM Pfu-X DNA polymerase was used, and PCR amplification conditions were as follows: denaturation at 95°C for 2 minutes, denaturation at 95°C for 20 seconds, annealing at 60°C for 40 seconds, polymerization at 72°C for 1 minute, repeated 27 times, and then polymerization reaction at 72°C for 5 minutes.
[0275]
[0276] Sequence number name Sequence (5'→3') Sequence number 30 ppsA (C.gl) - FcaacgaaaggaaacactcATGACCAACAGTTTGAACATCC Sequence number 31 ppsA (C.gl) - RACAATCACCGCATCCagtTTACTTCGTGCCGGTCATTG
[0277] In addition, to secure the Pcj7 promoter, PCR was performed using primers of SEQ ID NO: 17 and SEQ ID NO: 32 with p117-cj7-gfp (US 7662943 B2) as a template. The polymerase was Solg TMPfu-X DNA polymerase (SolGent co.) was used, and the PCR amplification conditions were as follows: denaturation at 95°C for 2 minutes, denaturation at 95°C for 20 seconds, annealing at 60°C for 40 seconds, polymerization at 72°C for 30 seconds, repeated 27 times, and then polymerization was performed at 72°C for 5 minutes.
[0278]
[0279] Sequence number name sequence (5'→3') Sequence number 32Pcj7(C.gl)-RCAAACTGTTGGTCATgagtgtttcctttcgttggg
[0280] Next, the amplified ppsA gene of Corynebacterium glutamicum ATCC13869, the Pcj7 promoter region, and the pDCM2-△Tn constructed in Example 2-1, which was cut with the ScaI restriction enzyme, were cloned using the Gibson assembly method (DG Gibson et al., NATURE METHODS, VOL.6 NO.5, MAY 2009, NEBuilder HiFi DNA Assembly Master Mix) to obtain a recombinant plasmid, which was named pDCM2-△Tn:: Pcj7-ppsA(C.gl). Cloning was performed by mixing the Gibson assembly reagent and each gene fragment in the calculated molar number and then storing it at 50℃ for 1 hour.
[0281]
[0282] Next, the constructed pDCM2-△Tn:: Pcj7-ppsA(C.gl) vector was transformed into the tryptophan-producing strain CM05-9157 (Korean Patent No. 10-2278000) by electroporation (Appl. Microbiol. Biotechnol. (1999) 52:541-545), and a second crossing-over process was performed to obtain a strain in which one copy of the Pcj7-ppsA(C.gl) gene was inserted between transposon genes on the chromosome. The strain was identified by PCR using primers of SEQ ID NOs: 19 and 20, which can amplify the external regions of the upstream and downstream regions of the inserted gene, respectively, and by sequencing.
[0283]
[0284] The strain obtained by the above method was named CM05-9157 :: Pcj7-ppsA(C.gl).
[0285]
[0286] Example 3. Evaluation of L-tryptophan production ability of L-tryptophan-producing microorganisms introduced with foreign pyruvate, phosphate dikinase genes or their orthologs.
[0287]
[0288] In order to confirm the L-tryptophan production ability of the CM05-9157 :: Pcj7-ppdK (K.xy), CM05-9157 :: Pcj7-ppdK (A.pa), CM05-9157 :: Pcj7-ppdK (M.ac), CM05-9157 :: Pcj7-ppsA (E.co) strains produced in Examples 2-2, 2-3, 2-4, and 2-5 respectively; and the parent strain CM05-9157 without the introduction of a foreign gene and the CM05-9157 :: Pcj7-ppsA (C.gl) strain produced in Example 1-6; they were cultured using the following method.
[0289] Each strain was inoculated into a 250-mL corner-baffle flask containing 25 mL of seed medium and cultured at 30°C for 20 hours with shaking at 200 rpm. Then, 1 mL of the seed culture was inoculated into a 250-mL corner-baffle flask containing 25 mL of production medium and cultured at 30°C for 24 hours with shaking at 200 rpm. After completion of the culture, the production amount of L-tryptophan was measured by HPLC. The compositions of the seed medium and production medium are as follows, and the concentration of L-tryptophan in the culture solution for each strain tested is shown in Table 14 below.
[0290]
[0291] <Seed medium (pH 7.0)>
[0292] Glucose 20 g, peptone 10 g, yeast extract 5 g, urea 1.5 g, KH2PO4 4 g, K2HPO4 8 g, MgSO4 7H2O 0.5 g, biotin 100 μg, thiamine HCl 1000 μg, calcium-pantothenic acid 2000 μg, nicotinamide 2000 μg (per 1 liter of distilled water).
[0293]
[0294] <Production medium (pH 7.0)>
[0295] Glucose 30 g, (NH4)2SO4 15 g, MgSO4 7H2O 1.2 g, KH2PO4 1 g, yeast extract 5 g, biotin 900 μg, thiamine hydrochloride 4500 μg, calcium-pantothenic acid 4500 μg, CaCO3 30 g (based on 1 liter of distilled water).
[0296]
[0297] OD562Tryptophan production (g / L)Tryptophan yield (*100 g / g, %)CM05-915756.51.886.37CM05-9157 :: Pcj7-ppsA(C.gl)56.31.896.38CM05-9157 :: Pcj7ppsA(E.co)56.11.96.40CM05-9157 :: Pcj7-ppdK(A.pa)56.81.856.34CM05-9157 :: Pcj7-ppdK(K.xy)52.12.357.52CM05-9157 :: Pcj7-ppdK(M.ac)57.81.645.51
[0298] As a result, as shown in Table 14 above, the tryptophan production of the CM05-9157 :: Pcj7-ppsA (C.gl) strain into which the phosphoenolpyruvate synthase gene derived from Corynebacterium glutamicum was introduced was 1.89 g / L, which was confirmed to be almost the same as the tryptophan production of the parent strain, CM05-9157.
[0299] In addition, among the pyruvate, phosphate dikinase genes or its ortholog, phosphoenolpyruvate synthase genes, derived from various microorganisms, only the CM05-9157 :: Pcj7-ppdK (K.xy) strain into which the pyruvate, phosphate dikinase gene derived from Komagataebacter xylinus was introduced produced a final L-tryptophan of 2.35 g / L in flask culture, confirming an increase in L-tryptophan production of approximately 18% compared to the parent strain CM05-9157 and / or CM05-9157 :: Pcj7-ppsA (C.gl) strain.
[0300] On the other hand, in three strains (CM05-9157 :: Pcj7-ppdK (A.pa), CM05-9157 :: Pcj7-ppdK (M.ac), CM05-9157 :: Pcj7-ppsA (E.co)) in which foreign phosphoenolpyruvate synthase or pyruvate, phosphate dikinase other than those derived from Komagateibacter xylinus were introduced, it was confirmed that tryptophan production was slightly reduced or the increase was relatively small compared to the control strain CM05-9157.
[0301] These results imply that only when a specific Komagataebacter xylinus-derived pyruvate phosphate dikinase gene is introduced into a Corytebacterium genus microorganism can L-tryptophan production be specifically increased.
[0302]
[0303] From the above description, those skilled in the art will understand that the present application can be implemented in other specific forms without altering its technical concept or essential characteristics. In this regard, it should be understood that the embodiments described above are illustrative in all respects and not restrictive. The scope of this application should be interpreted to include all changes or modifications derived from the meaning and scope of the following claims and their equivalents, rather than the detailed description above.
Claims
1. A microorganism of the genus Corynebacterium having L-tryptophan production ability, into which a pyruvate phosphate dikinase protein derived from Komagataebacter xylinus or a polynucleotide encoding the same has been introduced.
2. A microorganism of the genus Corynebacterium, wherein the pyruvate, phosphate dikinase derived from Komagataebacter xylinus comprises an amino acid sequence having sequence number 1 or a sequence identity of 90% or more therewith.
3. A microorganism of the genus Corynebacterium, wherein the pyruvate, phosphate dikinase derived from Komagataebacter xylinus in the first paragraph is encoded by the ppdK gene.
4. In the first paragraph, the microorganism of the genus Corynebacterium is Corynebacterium glutamicum.
5. A Corynebacterium microorganism according to any one of claims 1 to 4, wherein the Corynebacterium microorganism has increased L-tryptophan production ability compared to a non-modified microorganism.
6. A method for producing L-tryptophan, comprising the step of culturing a Corynebacterium genus microorganism having L-tryptophan production ability, into which a pyruvate phosphate dikinase protein derived from Komagateibacter xylinus or a polynucleotide encoding the same has been introduced, in a medium.
7. A method according to claim 6, further comprising a step of recovering L-tryptophan from the cultured microorganism, a culture of the microorganism, a fermented product of the microorganism, or the culture medium.
8. A composition for producing L-tryptophan, comprising a Corynebacterium microorganism having L-tryptophan production ability, into which a pyruvate phosphate dikinase protein derived from Komagataebacter xylinus or a polynucleotide encoding the same has been introduced; a culture of the microorganism, a fermented product of the microorganism, or a combination of two or more thereof.
9. A use for producing L-tryptophan of a Corynebacterium microorganism having L-tryptophan production ability, wherein a pyruvate phosphate dikinase protein derived from Komagataebacter xylinus or a polynucleotide encoding the same has been introduced; a composition comprising a culture of the microorganism, a fermented product of the microorganism, or a combination of two or more thereof.
